<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16226</article-id><article-id pub-id-type="doi">10.25208/vdv16226</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОР ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Sjögren’s syndrome: pathophysiological basis of dermatological manifestations</article-title><trans-title-group xml:lang="ru"><trans-title>Синдром Шегрена: патофизиологические основы дерматологических проявлений</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6801-3452</contrib-id><contrib-id contrib-id-type="scopus">56126629300</contrib-id><contrib-id contrib-id-type="spin">7534-4443</contrib-id><name-alternatives><name xml:lang="en"><surname>Palkina</surname><given-names>Nadezhda V.</given-names></name><name xml:lang="ru"><surname>Палкина</surname><given-names>Надежда Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор</p></bio><email>Mosmannv@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University</institution></aff><aff><institution xml:lang="ru">Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2024-08-02" publication-format="electronic"><day>02</day><month>08</month><year>2024</year></pub-date><pub-date date-type="pub" iso-8601-date="2024-08-26" publication-format="electronic"><day>26</day><month>08</month><year>2024</year></pub-date><volume>100</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>25</fpage><lpage>30</lpage><history><date date-type="received" iso-8601-date="2023-10-09"><day>09</day><month>10</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2024-07-12"><day>12</day><month>07</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Palkina N.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Палкина Н.В.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Palkina N.V.</copyright-holder><copyright-holder xml:lang="ru">Палкина Н.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/16226">https://vestnikdv.ru/jour/article/view/16226</self-uri><abstract xml:lang="en"><p>Sjogren’s syndrome is a chronic autoimmune disease with a predominant involvement in the pathological process of secreting cells of the glands and their excretory ducts, which is accompanied by the development of generalized dryness of the skin and mucous membranes. This syndrome is one of the most common systemic diseases, but in dermatological practice it remains undiagnosed in almost half of patients with clinical manifestations. The article discusses current aspects of the pathogenesis of dermatological manifestations of Sjögren’s syndrome, which will allow a deeper understanding and systematization of the various mechanisms of development of this pathology for the formation of the correct clinical tactics with the choice of pathogenetically based treatment approaches, determining the individual prognosis for the patient, as well as helping to alleviate the course of the disease and in many ways improving the quality of life of patients.</p></abstract><trans-abstract xml:lang="ru"><p>Синдром Шегрена — хроническое аутоиммунное заболевание с преимущественным вовлечением в патологический процесс секретирующих клеток желез и их выводных протоков, что сопровождается развитием генерализованной сухости кожи и слизистых оболочек. Данный синдром является одним из наиболее распространенных системных заболеваний, однако в дерматологической практике он остается недиагностированным практически у половины пациентов, имеющих клинические проявления. В статье рассмотрены актуальные аспекты патогенеза дерматологических проявлений синдрома Шегрена, что позволит глубже понять и систематизировать различные механизмы развития данной патологии для формирования правильной клинической тактики с выбором патогенетически обоснованных подходов к лечению, определению индивидуального прогноза для пациента, а также способствовать облегчению течения заболевания и во многом улучшению качества жизни пациентов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Sjögren’s syndrome</kwd><kwd>sicca syndrome</kwd><kwd>pathogenesis</kwd><kwd>autoimmune disease</kwd><kwd>skin manifestations</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>синдром Шегрена</kwd><kwd>сухой синдром</kwd><kwd>патогенез</kwd><kwd>аутоиммунное заболевание</kwd><kwd>кожные проявления</kwd></kwd-group><funding-group><funding-statement xml:lang="en">Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University</funding-statement><funding-statement xml:lang="ru">Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Negrini S, Emmi G, Greco M, Borro M, Sardanelli F, Murdaca G, et al. Sjögren’s syndrome: a systemic autoimmune disease. Clin Exp Med. 2022;22(1):9–25. doi: 10.1007/s10238-021-00728-6</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Мартусевич Н.А. Первичный синдром Шегрена: диагностика и дифференциальная диагностика. Медицинские новости. 2005;1:28–36. [Martusevich NA. Primary Sjögren’s syndrome: diagnosis and differential diagnosis. Meditcinskie novosti. 2005;1:28–36. (In Russ.)]</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Mavragani CP, Moutsopoulos HM. Sjögren syndrome. CMAJ. 2014;186(15):E579–586. doi: 10.1503/cmaj.122037</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Maciel G, Crowson CS, Matteson EL, Cornec D. Prevalence of Primary Sjögren’s Syndrome in a US Population-Based Cohort. Arthritis Care Res (Hoboken). 2017;69(10):1612–1616. doi: 10.1002/acr.23173</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Васильев В.И. Клиника, диагностика и дифференциальная диагностика болезни Шегрена. Российский медицинский журнал. 2008;10:638. [Vasilev VI. Clinic, diagnosis and differential diagnosis of Sjögren’s disease. Rossiiskii meditcinskii zhurnal. 2008;10:638. (In Russ.)]</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Zhan Q, Zhang J, Lin Y, Chen W, Fan X, Zhang D. Pathogenesis and treatment of Sjogren’s syndrome: Review and update. Front Immunol. 2023;14:1127417. doi: 10.3389/fimmu.2023.1127417</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Teos LY, Alevizos I. Genetics of Sjögren’s syndrome. Clin Immunol. 2017;182:41−47. doi: 10.1016/j.clim.2017.04.018</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Alqahtani B, Daghestani M, Omair MA, Alenzi F, Alhamad EH, Tashkandy Y, et al. Single nucleotide polymorphisms in cytokine genes and their association with primary Sjögren’s syndrome in Saudi patients: A cross-sectional study. Saudi Med J. 2023;44(12):1232–1239. doi: 10.15537/smj.2023.44.12.20230490</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Parisis D, Chivasso C, Perret J, Soyfoo MS, Delporte C. Current State of Knowledge on Primary Sjögren’s Syndrome, an Autoimmune Exocrinopathy. J Clin Med. 2020;9(7):2299. doi: 10.3390/jcm9072299</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Mavragani CP, Tzioufas AG, Moutsopoulos HM. Sjögren’s syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects. Int Arch Allergy Immunol. 2000;123(1):46–57. doi: 10.1159/000024423</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Mavragani CP, Fragoulis GE, Moutsopoulos HM. Endocrine alterations in primary Sjogren’s syndrome: an overview. J Autoimmun. 2012;39(4):354–358. doi: 10.1016/j.jaut.2012.05.011</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Giacomelli R, Matucci-Cerinic M, Bombardieri S. Microchimerism in Sjögren’s syndrome. Ann Rheum Dis. 2002;61(12):1039–1040. doi: 10.1136/ard.61.12.1039</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Nakamura H, Horai Y, Shimizu T, Kawakami A. Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren’s Syndrome. Int J Mol Sci. 2018;19(8):2369. doi: 10.3390/ijms19082369</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Katayama I. Dry skin manifestations in Sjögren syndrome and atopic dermatitis related to aberrant sudomotor function in inflammatory allergic skin diseases. Allergol Int. 2018;67(4):448–454. doi: 10.1016/j.alit.2018.07.001</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Bernacchi E, Amato L, Parodi A, Cottoni F, Rubegni P, De Pità O, et al. Sjögren’s syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology. Clin Exp Rheumatol. 2004;22(1):55–62.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Gollins CE, de Berker D. Nails in systemic disease. Clin Med (Lond). 2021;21(3):166–169. doi: 10.7861/clinmed.2021-0243</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Kittridge A, Routhouska SB, Korman NJ. Dermatologic manifestations of Sjögren syndrome. J Cutan Med Surg. 2011;15(1):8–14. doi: 10.2310/7750.2010.09033</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Sugai S, Shimizu S, Tachibana J, Sawada M, Yoshioka R, Hirose Y, et al. Hypergammaglobulinemic purpura in patients with Sjögren’s syndrome: a report of nine cases and a review of the Japanese literature. Jpn J Med. 1989;28(2):148–155. doi: 10.2169/internalmedicine1962.28.148</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Васильев В.И., Пробатова Н.А., Тупицын Н.Н., Варламова Е.Ю., Логвиненко О.А., Ковригина А.М., и др. Лимфопролиферативные заболевания при болезни Шегрена. Онкогематология. 2007;3:16–26. [Vasiljev VI, Probatova NA, Tupitsyn NN, Varlamova EY, Logvinenko OA, Kovrigina AM, et al. Lymphoproliferative diseases in primary Sjogren’s syndrome. Oncohematology. 2007;3:16–26. (In Russ.)] doi: 10.17650/1818-8346-2007-0-3-16-26</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Furlan KC, Kakizaki P, Chartuni JC, Valente NY. Frontal fibrosing alopecia in association with Sjögren’s syndrome: more than a simple coincidence. An Bras Dermatol. 2016;91(5 Suppl 1):14–16. doi: 10.1590/abd1806-4841.20164526</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Shiohara T, Sato Y, Komatsu Y, Ushigome Y, Mizukawa Y. Sweat as an Efficient Natural Moisturizer. Curr Probl Dermatol. 2016;51:30–41. doi: 10.1159/000446756</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Huang YJ, Chih PL, Huang TH, Yu HS, Hsieh YL, Yu S. Skin Ultrastructural Findings in Acquired Generalized Hypohidrosis/Anhidrosis in a Patient with Subclinical Sjögren Syndrome. Acta Derm Venereol. 2017;97(8):981–983. doi: 10.2340/00015555-2690</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Sisto M, Ribatti D, Lisi S. Molecular Mechanisms Linking Inflammation to Autoimmunity in Sjögren’s Syndrome: Identification of New Targets. Int J Mol Sci. 2022;23(21):13229. doi: 10.3390/ijms232113229</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Boury-Jamot M, Daraspe J, Bonté F, Perrier E, Schnebert S, Dumas M, et al. Skin aquaporins: function in hydration, wound healing, and skin epidermis homeostasis. Handb Exp Pharmacol. 2009;(190):205–217. doi: 10.1007/978-3-540-79885-9_10</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Carvajal P, Bahamondes V, Jara D, Castro I, Matus S, Aguilera S, et al. The integrated stress response is activated in the salivary glands of Sjögren’s syndrome patients. Front Med (Lausanne). 2023;10:1118703. doi: 10.3389/fmed.2023.1118703</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Aksenenko MB, Palkina NV, Sergeeva ON, Sergeeva EYu, Kirichenko AK, Ruksha TG. miR-155 overexpression is followed by downregulation of its target gene, NFE2L2, and altered pattern of VEGFA expression in the liver of melanoma B16-bearing mice at the premetastatic stage. Int J Exp Pathol. 2019;100(5–6):311–319. doi: 10.1111/iep.12342</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Martinez-Rico JC, Ancer-Arellano J, Martinez-Moreno A, Ocampo-Garza SS, Ocampo-Candiani J, Chavez-Alvarez S. Frontal Fibrosing Alopecia and Autoimmune Disorders in a Hispanic Female. Skin Appendage Disord. 2020;6(6):362–365. doi: 10.1159/000507557</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Huang PH, Liao HT, Tsai CY. Severe Raynaud’s phenomenon and Sjögren’s syndrome with ferocious gangrene change and auto-amputation. Clin Med (Lond). 2019;19(1):85. doi: 10.7861/clinmedicine.19-1-85</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Астанин П.А., Наркевич А.Н., Гржибовский А.М. Эпидемиологические аспекты заболеваний кожи и подкожной клетчатки в Красноярском крае в 2009–2019 годах. Сибирское медицинское обозрение. 2021;3(129):96–100. [Astanin PA, Narkevich AN, Grzhibovskii AM. Epidemiological aspects in diseases of the skin and subcutaneous tissue in Krasnoyarsk krai in 2009–2019. Siberian Medical Review. 2021;3(129):96–100. (In Russ.)] doi: 10.20333/25000136-2021-3-96-100</mixed-citation></ref></ref-list></back></article>
